Although the negative association of sPD-L1 with overall survival (OS) has been widely demonstrated in chemotherapy-treated cancer patients [24,25,26,27,28], only a few studies have investigated its role in ICI-treated cancer patients [29], and no data are available for mesothelioma patients. This evidence concerns the gene SPDL1 and mesothelioma.